Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Immunol Invest ; 51(5): 1162-1169, 2022 Jul.
Article in English | MEDLINE | ID: mdl-33941028

ABSTRACT

In this study, we determined to interpret the effects of the interleukin (IL)1B gene rs1143634 C/T polymorphism on myocardial infarction (MI) risk. This study, conducted in a Chinese Han population, recruited 369 MI patients and 465 controls. The variant of IL1B gene (rs1143634 C/T polymorphism) was genotyped by PCR-RFLP method. In this study, a significant link was shown between the IL1B rs1143634 C/T polymorphism and MI risk. We found that the IL1B rs1143634 C/T polymorphism enhanced the risk of MI in this population. Subgroup analysis detected that the IL1B rs1143634 C/T polymorphism associated with MI susceptibility in males, smokers, and individuals with diabetes mellitus. In addition, the IL1B rs1143634 C/T polymorphism was related with the levels of blood lipids including low-density lipoprotein (LDL), and total cholesterol (TC). This study uncovers that the IL1B rs1143634 C/T polymorphism may associate with the risk and blood lipid levels of MI in an Eastern Chinese Han population.Abbreviations: MI: myocardial infarction; IL-1: Interleukin-1; SNP: single nucleotide polymorphism; BMI: Body Mass Index; HDL: high-density lipoprotein; TC: total cholesterol; TG: triglyceride; LDL: low-density lipoprotein; PCR: polymerase chain reaction; 95% CI: 95% confidence interval; OR: odds ratio.


Subject(s)
Interleukin-1beta , Myocardial Infarction , China/epidemiology , Cholesterol/blood , Cholesterol/genetics , Female , Genetic Variation/genetics , Humans , Interleukin-1/genetics , Interleukin-1beta/genetics , Lipids/blood , Lipids/genetics , Lipoproteins, LDL/blood , Lipoproteins, LDL/genetics , Male , Myocardial Infarction/blood , Myocardial Infarction/epidemiology , Myocardial Infarction/genetics , Polymorphism, Single Nucleotide
2.
Int Immunopharmacol ; 99: 108041, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34435580

ABSTRACT

BACKGROUND: CD14 is crucial in the progression of myocardial infarction (MI). Several studies have explored the association between the risk of MI and the CD14 C-260 T polymorphism, but have reported inconsistent results. METHODS: This study analyzed the association of the CD14 C-260 T polymorphism with susceptibility to MI. Totally, 240 MI patients and 298 normal subjects were included. The association between MI risk and the target polymorphism was assessed using 95% confidence intervals and odds ratios obtained through logistic regression. RESULTS: The T allele of the CD14 C-260 T polymorphism was linked with an elevated risk of MI in Chinese Han people; subgroup analysis indicated that this effect was associated with smoking, male gender, and hypertension. In addition, the data revealed that different genotype carriers of the CD14 C-260 T polymorphism showed significantly distinct TG levels in MI patients. CONCLUSION: Totally, the T allele of the CD14 C-260 T polymorphism is associated with an elevated risk of MI.


Subject(s)
Lipopolysaccharide Receptors/genetics , Myocardial Infarction/epidemiology , Myocardial Infarction/genetics , Triglycerides/blood , Asian People , Case-Control Studies , China/epidemiology , Correlation of Data , Female , Genetic Predisposition to Disease/epidemiology , Humans , Logistic Models , Male , Middle Aged , Odds Ratio , Polymorphism, Single Nucleotide/genetics , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...